Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients

Pentavalent antimonial drugs are habitually the first choice for treating leishmaniasis, although they possess well-known toxicity and may present some therapeutic failure. Lipid formulations of amphotericin B (LFAB) have been increasingly used for treating several types of leishmaniasis. However, t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta tropica 2004-10, Vol.92 (2), p.127-132
Hauptverfasser:	Amato, Valdir S., Rabello, Ana, Rotondo-Silva, Alexandre, Kono, Adriana, Maldonado, Tânia Patrícia H., Alves, Isabel C., Floeter-Winter, Lucile M., Neto, Vicente Amato, Shikanai-Yasuda, Maria Aparecida
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome - complications Acquired Immunodeficiency Syndrome - immunology Adult American tegumentary leishmaniasis Amphotericin B - administration & dosage Antiprotozoal Agents - administration & dosage Biological and medical sciences Cutaneous leishmaniasis Drug Combinations General aspects Human immunodeficiency virus Human protozoal diseases Humans Immunocompromised Host Infectious diseases Kidney Failure, Chronic - complications Kidney Failure, Chronic - immunology Leishmaniasis Leishmaniasis, Cutaneous - complications Leishmaniasis, Cutaneous - drug therapy Leishmaniasis, Cutaneous - immunology Leshmaniasis Lipid formulations of amphotericin B Liposomes - administration & dosage Male Medical sciences Middle Aged Parasitic diseases Phosphatidylcholines - administration & dosage Phosphatidylglycerols - administration & dosage Protozoal diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!